Transient ischemic attack medical therapy

Revision as of 00:55, 12 December 2016 by Aysha Aslam (talk | contribs)
Jump to navigation Jump to search

Transient ischemic attack Microchapters

Home

Main Stroke Page

Ischemic stroke Page

Hemorrhagic Stroke Page

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Transient Ischemic Attack from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

AHA/ASA Guidelines for Stroke

Future or Investigational Therapies

Case Studies

Case #1

Transient ischemic attack medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transient ischemic attack medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transient ischemic attack medical therapy

CDC on Transient ischemic attack medical therapy

Transient ischemic attack medical therapy in the news

Blogs on Transient ischemic attack medical therapy

Directions to Hospitals Treating Transient ischemic attack

Risk calculators and risk factors for Transient ischemic attack medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Medical Therapy

The approach to medical management of patients with transient ischemic attack may involve the following:
a) Early assessment and emergency management
b) Long term management and follow up

Early assessment and emergency management

  • Rapid transport to the hospital
  • History and examination
  • IV access
  • Fingerstick glucose to rule out hypoglycemia
  • EKG testing to rule out ongoing ischemia
  • Neuroimaging to rule out infarction

Risk assessment and management plan

After initial evaluation of patient, the decision to further manage the patient in the emergency department observation unit, hospital admission or outpatient follow up depends on no of factors which may include

  • ABCD2 scoring(AHA guidelines)
  • Assessment by emergency physician
  • Opinion of neurologist
  • Risk of future stroke or TIA
  • Patient preference
  • Local resources

Guidelines for the hospitalization of patients with TIA

AHA guidelines

NSA guidelines

24-48 hours

  • Hospitalization recommended for early t-PA availability in case of recuurent attack or infarction
  • Early risk assessment and management plan

<1 week Hospitalization in less than a week of TIA may be recommended in following situations:

  • Symptoms >1 hour
  • Known hypercoaguable disorder
  • Symptomatic internal carotid artery stenosis>50
  • Two or more TIAs per week (crescendo TIA)
  • Cardiac source of embolism (atrial fibrillation)
  • California and ABCD2 suggesting admission

Pharmacological therapy

Hypertension

  • Blood pressure control may be considered in patients with evidence of end organ damage or levels above 220/120mmHg
  • Blood pressure autoregulation without medication may be considered in patients with increased levels in patients with TIA to enhance cerebral perfusion

Non cardioembolic TIA

Cardioembolic TIA

  • Anticoagulation may be recommended in patients with known cardiac source of emboli such as atrial fibrillation and acute MI with ventricular thrombus
  • Anticoagulation therapy with warfarin may be recommended with target INR 2-3
  • Aspirin 325mg may be recommended in patients unable to take anticoagulants

Long Term management

References

Template:WH Template:WS